Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

ACL Reconstruction clinical trials

4 of 5 indexed ACL Reconstruction trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 4 currently recruiting · #3,391 of 28,707 conditions by registered trial count

ACL Reconstruction: 5 US clinical trials tracked, 4 recruiting.

ACL Reconstruction is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Illinois Center for Orthopaedic Research and Education, running 1 of these trials.

Enrollment posture brief

Registry condition acl-reconstruction

OPEN 4 | RECR 80% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1

Nearest open-share peer: Acute Leukemia of Ambiguous Lineage (80% recruiting · 10 trials)

Ablation80%ACL Reconstruction (this)80%Abuse, Drug60%Acceptability60%Acral Lentiginous Melanoma20%
Open-enrollment share among volume-matched conditions near ACL Reconstruction

ACL Reconstruction lists 4 open slots (80% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for ACL Reconstruction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. ACL Reconstruction is recruiting above its size-band peers.

    4 of 5 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates ACL Reconstruction research.

    Illinois Center for Orthopaedic Research and Education accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical ACL Reconstruction enrolment sits around 102 participants.

    Median target enrolment is 102 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. ACL Reconstruction research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on ACL Reconstruction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

observe when return to school after surgery Other
1 trials
ACL Reconstruction Procedure
1 trials
Arthrex Internal Brace Device
1 trials
Non-semiconducting fabric sleeves Device
1 trials
Semiconducting fabric sleeves Device
1 trials
Protein + BAA Dietary supplement
1 trials
Whey protein isolate Dietary supplement
1 trials
Physical therapy Other
1 trials

US sites by state

Facility locations filed on ACL Reconstruction trials. A trial with sites in several states counts in each.

Texas 2 trials
New York 1 trials
Missouri 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this ACL Reconstruction page

5 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This ACL Reconstruction condition card totals 5 registered trials; most-linked intervention observe when return to school after surgery; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.